Evidence map›Paper›PMID 37505374›Full record

ArticleAdvances in therapy2023

Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach.

Dave Singh, Diego Litewka, Rafael Páramo, Adrian Rendon, Abdullah Sayiner, Suzana E Tanni, Sudeep Acharya, Bhumika Aggarwal, Afisi S Ismaila, Raj Sharma and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Advances in therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Dave SinghCentre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Diego LitewkaPulmonology Unit, Hospital General de Agudos Dr. J. A. Fernández, Buenos Aires, Argentina.
Rafael PáramoUniversidad Anáhuac, Querétaro, México.
Adrian RendonUniversidad Autónoma de Nuevo León, Servicio de Neumología, CIPTIR, Monterrey, NL, México.
Abdullah SayinerDepartment of Chest Diseases, Ege University Faculty of Medicine, İzmir, Turkey.
Suzana E TanniDepartment of Botucatu Medical School, Universidade Estadual Paulista, São Paulo, Brazil.
Sudeep AcharyaEmerging Markets, GSK, Singapore, Singapore.
Bhumika AggarwalEmerging Markets, GSK, Singapore, Singapore.
Afisi S IsmailaValue Evidence and Outcomes, GSK, Collegeville, PA, USA.
Raj SharmaGSK, Brentford, UK.
Peter Daley-YatesClinical Pharmacology and Experimental Medicine, GSK, Brentford, London, UK. peter.t.daley-yates@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37505374
PMCPMC10500000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.